Kiniksa Pharmaceuticals International, PLC (KNSA) SEC Filings — 2024
28 SEC filings for Kiniksa Pharmaceuticals International, PLC (KNSA) in 2024.
Filings
- Kiniksa Pharmaceuticals International, PLC SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Kiniksa Pharmaceuticals International, PLC SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Kiniksa Pharmaceuticals International, PLC SC 13G/A Filing — SC 13G/A · Nov 13, 2024
- Kiniksa Pharmaceuticals International, PLC SC 13G Filing — SC 13G · Nov 8, 2024
- Kiniksa Pharmaceuticals Files 8-K on Operations — 8-K · Oct 29, 2024
- Kiniksa Pharma Files Q3 2024 10-Q — 10-Q · Oct 29, 2024
- Kiniksa Pharmaceuticals International, PLC SC 13G Filing — SC 13G · Oct 21, 2024
- Baker Bros. Advisors Updates Kiniksa Pharma Stake — SC 13D/A · Oct 8, 2024
- Kiniksa Appoints New CEO, Dr. Sanj K. Patel — 8-K · Oct 7, 2024
- Kiniksa Pharmaceuticals Q2 2024 Update — 10-Q · Jul 25, 2024
- Kiniksa Pharmaceuticals Files 8-K on Operations — 8-K · Jul 23, 2024
- Kiniksa Pharmaceuticals Enters Material Definitive Agreement — 8-K · Jun 25, 2024
- Kiniksa Pharmaceuticals Files 8-K Report — 8-K · Jun 14, 2024
- Kiniksa Pharmaceuticals Files 8-K on Shareholder Vote Matters — 8-K · Jun 5, 2024
- Kiniksa Pharma Files Proxy Statement for Shareholder Meeting — DEFA14A · May 29, 2024
- Kiniksa Pharmaceuticals, Ltd. Files 10-Q for Period Ending March 31, 2024 — 10-Q · Apr 25, 2024
- Kiniksa Pharmaceuticals Schedules 2024 Annual Meeting and Special Redomiciliation Meeting — DEF 14A · Apr 23, 2024
- Kiniksa Pharmaceuticals, LTD. SC 13G/A Filing — SC 13G/A · Apr 5, 2024
- Kiniksa Pharmaceuticals Files 8-K — 8-K · Apr 2, 2024
- Kiniksa Pharmaceuticals Files 8-K — 8-K · Mar 29, 2024
- Kiniksa Pharmaceuticals Files 8-K on Financial Condition — 8-K · Feb 28, 2024
- Kiniksa Pharmaceuticals, Ltd. Files 2023 Annual Report on Form 10-K — 10-K · Feb 28, 2024
- Kiniksa Pharmaceuticals, LTD. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Kiniksa Pharmaceuticals, LTD. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Kiniksa Pharmaceuticals, LTD. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Rubric Capital Discloses 2.9M Share Stake in Kiniksa Pharma — SC 13G · Feb 12, 2024
- BlackRock Discloses Significant Stake in Kiniksa Pharma — SC 13G · Jan 25, 2024
- Kiniksa Pharma Files 8-K on Operations & Financial Condition — 8-K · Jan 4, 2024